Mohammad Asad

𝐖𝐨𝐫𝐤 𝐰𝐢𝐭𝐡 𝐐𝐮𝐚𝐥𝐭𝐞𝐜𝐡 𝐢𝐧 𝐀𝐮𝐬𝐭𝐫𝐚𝐥𝐢𝐚🦘 Australia's MedTech market is booming! Did you know Australia has: ✅𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝗮𝗰𝗵: 79 countries have devices registered for use in Australia. ✅𝗥𝗮𝗽𝗶𝗱 𝗚𝗿𝗼𝘄𝘁𝗵: There were a staggering 4169 new device registrations in 2022 alone! ✅𝗦𝘁𝗿𝗼𝗻𝗴 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁: Australians spend a significant portion of their GDP (10.7% in 2020-2021) on healthcare. 🇦🇺 ($8,617 per person!) Qualtech Consulting Corporation can be your partner in navigating this exciting market. 𝗛𝗲𝗿𝗲'𝘀 𝗵𝗼𝘄 𝘄𝗲 𝗰𝗮𝗻 𝗵𝗲𝗹𝗽 𝘆𝗼𝘂 𝘀𝘂𝗰𝗰𝗲𝗲𝗱: 🎯𝙈𝙪𝙡𝙩𝙞𝙥𝙡𝙚 𝙈𝙖𝙧𝙠𝙚𝙩 𝘼𝙘𝙘𝙚𝙨𝙨: We have a proven track record of securing approvals in various countries. 🎯𝙀𝙭𝙥𝙚𝙧𝙩 𝙂𝙪𝙞𝙙𝙖𝙣𝙘𝙚: With over 20 years of experience and 5,000 successful product approvals, we know the ropes! 𝗖𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀 𝗶𝗻 𝗔𝘂𝘀𝘁𝗿𝗮𝗹𝗶𝗮: 👉TGA Regulatory Submissions 👉Post-Market Surveillance (PMS) and Advertisement Support 👉ARTG Listing Assistance ️ 👉Strategic Market Planning 👉Sponsorship Services Ready to unlock the potential of Australia's thriving MedTech market? 📞Contact Qualtech today and let's discuss your specific needs! #Qualtech #MedTech #Australia #MarketAccess #RegulatoryAffairs

15

Australia and New Zealand are often target countries for MedTech companies looking to expand into a new market. Due to their bilateral agreement on medical device regulation and acceptance of several overseas device certifications, the two countries may present a relatively simple regulatory pathway for many devices. So, for anyone considering Australia and New Zealand as the next market for their device, here’s what you’ll need to know about the regulatory landscape... Continue reading 👉 https://bit.ly/3ww9goW

16

🚀 Australian Healthcare Transformation: How AUCDI Impacts You 🚀 Another acronym that might sound irrelevant to many is "The Australian Core Data for Interoperability" (AUCDI) because it is a foundation for improving our healthcare systems' digital capabilities. AUCDI sets the stage for Australia's more integrated, efficient, and patient-centric healthcare system. 3 Ways AUCDI will impact Australians who receive treatment in our healthcare system 1. Easier Access to Your Health Info: Quickly access your complete health profile from any provider in Australia 2. Safer Treatments: Reduced errors and improved outcomes through seamless information sharing 3. Personalised Healthcare: Tailored care plans based on a comprehensive understanding of your health history. 3 Ways AUCDI will impact Healthcare Professionals who provide treatment in our healthcare system 1. Streamlined Processes: Simplify how you access and share patient data across systems 2. Informed Decisions: Make better clinical decisions with detailed, real-time data at your fingertips 3. Enhanced Collaboration: Work more effectively with other healthcare providers, improving patient outcomes 4. Future-Ready: Adapt quickly to new health technologies and standards 5. Reduced Redundancy: Spend less time on paperwork and more on patient care. https://lnkd.in/dBQSxMWY

5

This week's #MedTechNews round-up delves into #AI in #MedTech, pioneering technologies, FDA approvals, and acquisitions, raising the crucial question: How can healthcare balance AI integration with traditional practices for better patient care? #Queensland Premier Steven Miles supports Gold Coast University Hospital's initiative to pioneer AI technology for medical scans, aiming to expedite X-rays, MRIs, ultrasounds, and CT scans. The hospital, in the tender phase, plans a clinical trial by 2025 to enhance radiologists' efficiency by 20% and potentially boost staff productivity, following the clearance of a 54,000-image backlog due to shortages. This initiative aligns with national efforts; South Australia's hospitals already use AI, and NSW Health has an AI framework, while the Australian Medical Association emphasises transparent AI healthcare implementation. https://lnkd.in/gD3W2Phd Doctors from Jefferson's Farber Institute and the Rothman Orthopaedic Institute created the NeuroSleeve, a device for patients with paralysis. The wearable device uses patient-controlled robotic assistance, electrical stimulation, and soft robotics to address movement deficits and can accept signals from implanted brain sensors from companies like Precision Neuroscience, Paradromics Inc., Synchron, and Neuralink. https://lnkd.in/gxMZkyUn The CE mark approved Roche's Accu-Chek SmartGuide CGM system for adults over 18 with type 1 or type 2 diabetes using flexible insulin therapy, offering a 14-day wear time, simplicity, and waterproof design. It uses predictive AI to provide real-time glucose readings every five minutes via a sensor and app, managing diabetes by predicting glucose levels and alerting to hypoglycemia risks. https://lnkd.in/gnrp8Wtm Masimo's $1 billion acquisition of Sound United aimed to expand pulse oximetry into consumer markets but caused a 37% stock decline. Masimo is now planning to undo it by spinning off its consumer business and negotiating a joint venture sale. A potential partner proposes acquiring a majority stake after due diligence, with Masimo aiming to retain control of its IP, including litigation with Apple, pending a July board meeting where activist investor Politan Capital seeks influence; analysts foresee potential divestiture by late 2024 or mid-2025. https://lnkd.in/gCJU-rNn Follow TRESP Recruitment - Medtech and Healthtech Experts for the latest updates and insights into the evolving medical technology landscape. #MedTechNews #MedicalDevices #HealthcareInnovation #MedTechIndustry #HealthTech #HealthcareTechnology #MedDeviceNews #HealthcareNews #MedTechTrends

7